Sangamo Therapeutics announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease

Click here to view

Presentation

Zinc Finger Activators restore normal gene and protein expression in a mouse model of SCN2A haploinsufficiency

Download PDF